Search results for: 'ICT Market Forecast'

Cardiology is the second-largest generator of patient image data and reports, which need to be stored/archived, analyzed, and managed. This, coupled with hospitals need to provide timely, high-quality care to patients, given the urgency of cardiology cases, necessitates a holistic view of cardiac patient data and a well-connected, enterprise-wide ...

This Frost & Sullivan annual outlook analyzes the medical devices industry across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The study provides insights into market size, growth rates, opportunities, strategic imperatives, and macroeconomic trends shaping the medical devices industry. The study period spans 202...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patient-facing applications, and interoperable care eco...

08 Feb 2023  |  North America  |  Market Research

Growth Opportunities in the Global Cloud-based Medical Imaging Informatics Market, Forecast to 2026

Conventional Medical Imaging Informatics Shifts to AI-based Consolidated Solutions

Infographics

×

Medical imaging informatics solution deployment is shifting from the on-premises model to a cloud-based infrastructure. The conventional on-premises model, which requires every enterprise to buy, operate, and maintain its own cumbersome IT infrastructure and solutions, proves unsustainable in the era of big data. It is also short-sighted given the ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

21 Dec 2016  |  Africa  |  Market Research

African Pharmaceuticals Market, Forecast to 2020

Assessing Market Potential with a Focus on Kenya and Nigeria

Infographics

×

The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest re...

06 May 2016  |  Asia Pacific  |  Market Research

Global Generic Pharmaceuticals Market, Forecast to 2020

Market Participants Target High Value-added Branded Generics and Biosimilars Segments

Infographics

×

The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

29 Jan 2016  |  Africa  |  Market Research

Ethiopian Pharmaceutical Market, Forecast to 2020

Preference for Generic Prescription Drugs to Create New Market Dynamics, Demand for Anti-Infectives Rises

Infographics

×

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and trans...